Sugi Predict

Sugi Predict / Compounds / SCHEMBL531399

SCHEMBL531399

SCHEMBL531399

COc1ccc(C(C)=O)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.65
▸ HPGD P15428 2/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ MAPK1 P28482 1/20 0.65
▸ CPS1 P31327 11/20 0.63
▸ MAOB P27338 4/20 0.58
▸ MAOA P21397 1/20 0.55
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ MEN1 O00255 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29639738 1.00 ALDH1A1 (0.65) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL14016072 0.87 CPS1 (0.58) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL2324673 0.85 CPS1 (0.59) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL31741591 0.85 ALDH1A1 (0.59) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL5196960 0.85 ALDH1A1 (0.59) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL1051747 0.85 CPS1 (0.63) ALDH1A1HPGDCPS1NPC1RAB9A
SCHEMBL28102429 0.84 CPS1 (0.57) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL72082 0.83 CPS1 (0.61) ALDH1A1HPGDCPS1NPC1RAB9A
SCHEMBL1555099 0.83 CPS1 (0.61) ALDH1A1HPGDCYP3A4MAPK1CPS1
SCHEMBL15226106 0.83 CPS1 (0.61) ALDH1A1HPGDCYP3A4MAPK1CPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114146071-B Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome 西北农林科技大学深圳研究院 2023-02-28 — — CN claimed
CN-114146071-A Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome 西北农林科技大学深圳研究院 2022-03-08 — — CN claimed
CN-211051377-U Stirring device for preparing 2-fluoro-4-methoxyacetophenone 成都蕴意典生物技术有限公司 2020-07-21 — — CN claimed
CN-110734367-A diphenyl ether chalcone tubulin inhibitor and preparation method and application thereof 贵州医科大学 2020-01-31 — — CN claimed
CN-209646348-U A kind of preparation facilities of 2- fluoro-4-methoxyacetophenone CHENGDU YUNYIDIAN BIOTECHNOLOGY CO LTD 2019-11-19 — — CN claimed
CN-209464936-U Proportioner is used in a kind of production of 2- fluoro-4-methoxyacetophenone 成都蕴意典生物技术有限公司 2019-10-08 — — CN claimed
CN-209464914-U A kind of 2- fluoro-4-methoxyacetophenone storage equipment 成都蕴意典生物技术有限公司 2019-10-08 — — CN claimed
CN-107365324-B A kind of synthetic method of (the fluoro- 5- isopropyl -2- anisyl of 4-) boric acid 西安瑞联新材料股份有限公司 2019-05-10 — — CN claimed
CN-102304035-B Preparation method of 2-fluoro-4-methoxyacetophenone ANHUI DONGJIAN CHEMICAL TECHNOLOGY CO LTD 2015-02-04 — — CN claimed
CN-102304035-A Preparation method of 2-fluoro-4-methoxyacetophenone ANHUI DONGJIAN CHEMICAL INDUSTRY CO LTD 2012-01-04 — — CN claimed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 — — US disclosed
US-12404253-B2 2,4,6-trisubstituted 1,3,5-triazines as modulators of CX3CR1 ASTRAZENECA AB (SE) 2025-09-02 — — US disclosed
EP-4605388-A1 <SUP2/>? <SUB2/>?3?2,4,6-TRISUBSTITUTED 1,3,5-TRIAZINES AS MODULATORS OF CXCR1 Astrazeneca AB (SE) 2025-08-27 — — EP disclosed
WO-2025137310-A1 CRYSTALLINE GPR40 AGONIST AND METHODS OF MAKING KALLYOPE, INC. (US) 2025-06-26 — — WO disclosed
US-20240408216-A1 PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE JING MEDICINE TECHNOLOGY (SHANGHAI) LTD. (CN) 2024-12-12 — — US disclosed
EP-0255728-A2 Phenoxyacetic acid compounds, their preparation, pharmaceutical composition and use TANABE SEIYAKU CO., LTD. (JP) 1988-02-10 — — EP disclosed
EP-0233706-A2 Halogen-containing heterocyclic compounds and liquid crystal compositions containing them Chisso Corporation (JP) 1987-08-26 — — EP disclosed
EP-0206021-A1 Derivatives of 1,1,2,2-tetramethyl-1,2-bis(2-fluoro-4-hydroxyphenyl) ethane ASTA Pharma AG (DE) 1986-12-30 — — EP disclosed
EP-0106565-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-09-10 — — EP disclosed
EP-0106565-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12404253-B2 2,4,6-trisubstituted 1,3,5-triazines as modulators of CX3CR1 CX3CR1, CCR2, CCR5 ALDH1A1 1531/4885HPGD 1142/4885CYP3A4 2998/4885
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK ALDH1A1 4075/4885HPGD 1259/4885CYP3A4 4471/4885
US-20240408216-A1 PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE PSME1, IDE, PRUNE1 ALDH1A1 4213/4885HPGD 2243/4885CYP3A4 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.